DENTSPLY SIRONA Inc. reported $3.64B of revenue over the trailing twelve months, −0.76% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $3.64B (to Q2 2026). Net income: −$546M, trailing twelve months to Q2 2026. Free cash flow: $143M, trailing twelve months to Q2 2026. Operating margin: −8.4%, trailing twelve months to Q2 2026.

XRAYDENTSPLY SIRONA Inc.

Healthcare

$8.84-31% 1Y

$8.84

$8.5352 weeks$14.68

XRAY as reported

DENTSPLY SIRONA Inc. reported $3.64B of revenue over the trailing twelve months, −0.76% on the year before. 11 reported series are charted on this page, each one as filed.

$3.64B

Revenue, trailing twelve months · to Q2 2026 · −0.76% against the twelve months before

Net income: −$546M
Net income · −42% year on year · trailing twelve months to Q2 2026
Free cash flow: $143M
Free cash flow · +3.6% year on year · trailing twelve months to Q2 2026
Operating margin: −8.4%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for XRAY, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$3.64B	−0.76%	Q2 2026
Net income	−$546M	−42%	Q2 2026
EPS	−$2.74	−42%	Q2 2026
Gross margin	50%	n/a	Q2 2026
Operating margin	−8.4%	n/a	Q2 2026
Net margin	−15%	n/a	Q2 2026
ROE	−48%	n/a	Q2 2026
ROA	−12%	n/a	Q2 2026
ROIC	−12%	n/a	Q2 2026
Free cash flow	$143M	+3.6%	Q2 2026
P/E	25.8	n/a	Q2 2022 · 16 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.